Geranylgeraniol restores cell growth and Ras processing in mevalonate-depleted fibroblast cells

F. Gao, Raymond Hohl, T. K. Shires

Research output: Contribution to journalArticle

Abstract

Eukaryotic cells are dependent upon the availability of mevalonate for normal growth. This requirement supplies mevalonate-derived isoprenoids that are necessary for the posttranslational modification of a large number of growth-regulating proteins, including those of the Ras family. Recently, metabolic labeling experiments have suggested that some mammalian cells can utilize geranylgeraniol (GGOH) and farnesol (FOH) for protein isoprenylation although the metabolic pathway underlying this phenomenon is not described. To further characterize isoprenoid metabolism we incubated wild-type and H-ras transfected (EJ-6-2-Bam-6a) NIH 3T3 cells with lovastatin, an inhibitor of hydroxymethylglutaryl coenzyme A reductase that depletes cells of mevalonate, for 24 hours. In both cell types proliferation, assessed as radiolabeled thymidine incorporation into DNA, was impaired at lovastatin levels greater than 1 μM in a concentration-dependent fashion; 5 mM mevalonate restored cell proliferation. The growth inhibition induced by 100 μM lovastatin was reversed by 5 μM GGOH, but not by FOH. The impairment of Ras isoprenylation, determined by Western blot analysis of fractionated cell lysate using a pan-anti-Ras antibody linked to a horseradish peroxidase detection system, by 100 μM lovastatin was partially reversed by 50 μM GGOH, but not by FOH, in NIH 3T3 cells only. These results are consistent with the existence of a metabolic pathway for deriving isoprenoid intermediates from GGOH but suggest that differences in this pathway exist between wild-type and H-ras transformed NIH 3T3 cells.

Original languageEnglish (US)
JournalFASEB Journal
Volume12
Issue number5
StatePublished - Mar 20 1998

Fingerprint

Lovastatin
Mevalonic Acid
Cell growth
Fibroblasts
NIH 3T3 Cells
fibroblasts
cell growth
Terpenes
lovastatin
Cells
Growth
Processing
Metabolic Networks and Pathways
isoprenoids
Protein Prenylation
Farnesol
Cell Proliferation
cells
Prenylation
Hydroxymethylglutaryl-CoA Reductase Inhibitors

All Science Journal Classification (ASJC) codes

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

@article{824db4a5d58f43188192dcb469d54084,
title = "Geranylgeraniol restores cell growth and Ras processing in mevalonate-depleted fibroblast cells",
abstract = "Eukaryotic cells are dependent upon the availability of mevalonate for normal growth. This requirement supplies mevalonate-derived isoprenoids that are necessary for the posttranslational modification of a large number of growth-regulating proteins, including those of the Ras family. Recently, metabolic labeling experiments have suggested that some mammalian cells can utilize geranylgeraniol (GGOH) and farnesol (FOH) for protein isoprenylation although the metabolic pathway underlying this phenomenon is not described. To further characterize isoprenoid metabolism we incubated wild-type and H-ras transfected (EJ-6-2-Bam-6a) NIH 3T3 cells with lovastatin, an inhibitor of hydroxymethylglutaryl coenzyme A reductase that depletes cells of mevalonate, for 24 hours. In both cell types proliferation, assessed as radiolabeled thymidine incorporation into DNA, was impaired at lovastatin levels greater than 1 μM in a concentration-dependent fashion; 5 mM mevalonate restored cell proliferation. The growth inhibition induced by 100 μM lovastatin was reversed by 5 μM GGOH, but not by FOH. The impairment of Ras isoprenylation, determined by Western blot analysis of fractionated cell lysate using a pan-anti-Ras antibody linked to a horseradish peroxidase detection system, by 100 μM lovastatin was partially reversed by 50 μM GGOH, but not by FOH, in NIH 3T3 cells only. These results are consistent with the existence of a metabolic pathway for deriving isoprenoid intermediates from GGOH but suggest that differences in this pathway exist between wild-type and H-ras transformed NIH 3T3 cells.",
author = "F. Gao and Raymond Hohl and Shires, {T. K.}",
year = "1998",
month = "3",
day = "20",
language = "English (US)",
volume = "12",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "5",

}

Geranylgeraniol restores cell growth and Ras processing in mevalonate-depleted fibroblast cells. / Gao, F.; Hohl, Raymond; Shires, T. K.

In: FASEB Journal, Vol. 12, No. 5, 20.03.1998.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Geranylgeraniol restores cell growth and Ras processing in mevalonate-depleted fibroblast cells

AU - Gao, F.

AU - Hohl, Raymond

AU - Shires, T. K.

PY - 1998/3/20

Y1 - 1998/3/20

N2 - Eukaryotic cells are dependent upon the availability of mevalonate for normal growth. This requirement supplies mevalonate-derived isoprenoids that are necessary for the posttranslational modification of a large number of growth-regulating proteins, including those of the Ras family. Recently, metabolic labeling experiments have suggested that some mammalian cells can utilize geranylgeraniol (GGOH) and farnesol (FOH) for protein isoprenylation although the metabolic pathway underlying this phenomenon is not described. To further characterize isoprenoid metabolism we incubated wild-type and H-ras transfected (EJ-6-2-Bam-6a) NIH 3T3 cells with lovastatin, an inhibitor of hydroxymethylglutaryl coenzyme A reductase that depletes cells of mevalonate, for 24 hours. In both cell types proliferation, assessed as radiolabeled thymidine incorporation into DNA, was impaired at lovastatin levels greater than 1 μM in a concentration-dependent fashion; 5 mM mevalonate restored cell proliferation. The growth inhibition induced by 100 μM lovastatin was reversed by 5 μM GGOH, but not by FOH. The impairment of Ras isoprenylation, determined by Western blot analysis of fractionated cell lysate using a pan-anti-Ras antibody linked to a horseradish peroxidase detection system, by 100 μM lovastatin was partially reversed by 50 μM GGOH, but not by FOH, in NIH 3T3 cells only. These results are consistent with the existence of a metabolic pathway for deriving isoprenoid intermediates from GGOH but suggest that differences in this pathway exist between wild-type and H-ras transformed NIH 3T3 cells.

AB - Eukaryotic cells are dependent upon the availability of mevalonate for normal growth. This requirement supplies mevalonate-derived isoprenoids that are necessary for the posttranslational modification of a large number of growth-regulating proteins, including those of the Ras family. Recently, metabolic labeling experiments have suggested that some mammalian cells can utilize geranylgeraniol (GGOH) and farnesol (FOH) for protein isoprenylation although the metabolic pathway underlying this phenomenon is not described. To further characterize isoprenoid metabolism we incubated wild-type and H-ras transfected (EJ-6-2-Bam-6a) NIH 3T3 cells with lovastatin, an inhibitor of hydroxymethylglutaryl coenzyme A reductase that depletes cells of mevalonate, for 24 hours. In both cell types proliferation, assessed as radiolabeled thymidine incorporation into DNA, was impaired at lovastatin levels greater than 1 μM in a concentration-dependent fashion; 5 mM mevalonate restored cell proliferation. The growth inhibition induced by 100 μM lovastatin was reversed by 5 μM GGOH, but not by FOH. The impairment of Ras isoprenylation, determined by Western blot analysis of fractionated cell lysate using a pan-anti-Ras antibody linked to a horseradish peroxidase detection system, by 100 μM lovastatin was partially reversed by 50 μM GGOH, but not by FOH, in NIH 3T3 cells only. These results are consistent with the existence of a metabolic pathway for deriving isoprenoid intermediates from GGOH but suggest that differences in this pathway exist between wild-type and H-ras transformed NIH 3T3 cells.

UR - http://www.scopus.com/inward/record.url?scp=33749195913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749195913&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33749195913

VL - 12

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 5

ER -